# SANUWAVE Health Inc. (SNWV)

Source: https://www.quantisnow.com/company/SNWV
Generated: 2026-11-17T12:14:36.433Z

- Ticker: SNWV
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- SEC CIK: 0001417663

## Latest SNWV news and filings

- 2026-11-13 20:55 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by SANUWAVE Health Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-sanuwave-health-inc-6790317)
- 2026-11-10 22:09 UTC [SEC Form 8-K] [SANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sanuwave-health-inc-filed-sec-form-8-k-results-of-operations-6784646)
- 2026-11-10 22:00 UTC [Earnings] [Sanuwave Announces Q3 FY2026 Financial Results](https://www.quantisnow.com/insight/sanuwave-announces-q3-fy2026-financial-results-6784568)
- 2026-11-10 21:45 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by SANUWAVE Health Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sanuwave-health-inc-6784502)
- 2026-11-06 21:30 UTC [Earnings Date] [Sanuwave Will Host a Conference Call on November 11, 2026 at 8:30 AM (ET) to Present Q3 2026 Financial Results](https://www.quantisnow.com/insight/sanuwave-will-host-a-conference-call-on-november-11-2026-6779190)
- 2026-11-05 14:08 UTC [Sanuwave Health Comments on 2027 Medicare Physician Fee Schedule Rate for Ultramist](https://www.quantisnow.com/insight/sanuwave-health-comments-on-2027-medicare-physician-fee-schedule-rate-6775190)
- 2026-10-28 21:15 UTC [SEC Form 8-K] [SEC Form 8-K filed by SANUWAVE Health Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-sanuwave-health-inc-6761815)
- 2026-10-02 21:07 UTC [SEC Form 4] [SEC Form 4 filed by Director Tyler James](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-tyler-james-6735184)
- 2026-10-02 21:06 UTC [SEC Form 4] [SEC Form 4 filed by Chief Executive Officer Frank Morgan C.](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-executive-officer-frank-morgan-6735179)
- 2026-10-02 21:03 UTC [SEC Form 4] [SEC Form 4 filed by Director Bazar Gregory Matthew](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-bazar-gregory-matthew-6735145)
- 2026-10-02 21:02 UTC [SEC Form 4] [SEC Form 4 filed by Director Blizard Jeffrey](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-blizard-jeffrey-6735139)
- 2026-10-02 21:01 UTC [SEC Form 4] [SEC Form 4 filed by Director Miller Ian D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-miller-ian-d-6735124)
- 2026-09-25 20:38 UTC [SEC Form 8-K] [SANUWAVE Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/sanuwave-health-inc-filed-sec-form-8-k-notice-of-delisting-6726630)
- 2026-08-06 21:07 UTC [SEC Form 8-K] [SANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sanuwave-health-inc-filed-sec-form-8-k-results-of-operations-6669940)
- 2026-08-06 21:00 UTC [Earnings Date] [Sanuwave Announces Q2 FY2026 Financial Results](https://www.quantisnow.com/insight/sanuwave-announces-q2-fy2026-financial-results-6669845)
- 2026-08-06 20:37 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by SANUWAVE Health Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sanuwave-health-inc-6669667)
- 2026-07-30 22:00 UTC [Earnings Date] [Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results](https://www.quantisnow.com/insight/sanuwave-will-host-a-conference-call-on-august-7-2026-6656708)
- 2026-07-13 20:38 UTC [SEC Form 8-K] [SANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sanuwave-health-inc-filed-sec-form-8-k-results-of-operations-6635580)
- 2026-07-13 20:30 UTC [Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance](https://www.quantisnow.com/insight/sanuwave-health-reports-preliminary-q2-2026-revenue-of-9698-million-6635494)
- 2026-07-02 20:13 UTC [SEC Form 4] [SEC Form 4 filed by Director Blizard Jeffrey](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-blizard-jeffrey-6625395)
- 2026-07-02 20:13 UTC [SEC Form 4] [SEC Form 4 filed by Director Miller Ian D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-miller-ian-d-6625382)
- 2026-07-02 20:12 UTC [SEC Form 4] [SEC Form 4 filed by Director Bazar Gregory Matthew](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-bazar-gregory-matthew-6625362)
- 2026-07-02 20:12 UTC [SEC Form 4] [SEC Form 4 filed by Director Tyler James](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-tyler-james-6625351)
- 2026-07-02 20:11 UTC [SEC Form 4] [SEC Form 4 filed by Chief Executive Officer Frank Morgan C.](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-executive-officer-frank-morgan-6625341)
- 2026-06-16 12:07 UTC [SEC Form 8-K] [SANUWAVE Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sanuwave-health-inc-filed-sec-form-8-k-regulation-fd-disclosure-6603978)
- 2026-06-16 12:00 UTC [Sanuwave Health Updates Second Quarter 2026 Guidance](https://www.quantisnow.com/insight/sanuwave-health-updates-second-quarter-2026-guidance-6603936)
- 2026-06-15 21:27 UTC [SEC Form 8-K] [SANUWAVE Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/sanuwave-health-inc-filed-sec-form-8-k-submission-of-matters-6603281)
- 2026-05-29 20:50 UTC [SEC Form SD filed by SANUWAVE Health Inc.](https://www.quantisnow.com/insight/sec-form-sd-filed-by-sanuwave-health-inc-6579674)
- 2026-05-12 21:00 UTC [Earnings Date] [Sanuwave Announces Revenues and Financial Results for Q1 FY2026](https://www.quantisnow.com/insight/sanuwave-announces-revenues-and-financial-results-for-q1-fy2026-6548757)
- 2026-05-12 20:33 UTC [SEC Form 8-K] [SANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sanuwave-health-inc-filed-sec-form-8-k-results-of-operations-6548538)
- 2026-05-12 20:32 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by SANUWAVE Health Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sanuwave-health-inc-6548526)
- 2026-05-06 21:00 UTC [Earnings Date] [Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results](https://www.quantisnow.com/insight/sanuwave-will-host-a-conference-call-on-may-13-2026-6536255)
- 2026-05-04 20:05 UTC [SEC Form 4] [Large owner Opaleye Management Inc. sold $574,240 worth of shares (35,581 units at $16.14) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-sold-574240-worth-of-shares-6528919)
- 2026-05-04 20:05 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by SANUWAVE Health Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-sanuwave-health-inc-6528892)
- 2026-04-30 20:10 UTC [SEC Form 4] [Large owner Opaleye Management Inc. sold $1,274,971 worth of shares (70,648 units at $18.05) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-opaleye-management-inc-sold-1274971-worth-of-shares-6524374)
- 2026-04-29 20:06 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by SANUWAVE Health Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-sanuwave-health-inc-6521170)
- 2026-04-29 20:05 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by SANUWAVE Health Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-sanuwave-health-inc-6521152)
- 2026-04-21 22:17 UTC [SEC Form 4] [SEC Form 4 filed by Opaleye Management Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-opaleye-management-inc-6509037)
- 2026-04-16 21:05 UTC [SEC Form 8-K] [SANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sanuwave-health-inc-filed-sec-form-8-k-results-of-operations-6503598)
- 2026-04-16 21:00 UTC [Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year](https://www.quantisnow.com/insight/sanuwave-health-reports-preliminary-q1-2026-revenue-of-9697-million-6503559)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SNWV
- Earnings history: https://www.quantisnow.com/earnings/SNWV
- Dividend history: https://www.quantisnow.com/dividends/SNWV
- Insider transactions: https://www.quantisnow.com/insiders/SNWV
- Options chain: https://www.quantisnow.com/options/SNWV
- SEC 8-K filings only: https://www.quantisnow.com/company/SNWV/8-k
- RSS and alerts for SNWV: https://www.quantisnow.com/docs/rss-feeds.md
